Jamilloux, Yvan

JAK inhibitors for the treatment of autoimmune and inflammatory diseases

Jamilloux, Y., El Jammal, T., Vuitton, L., Gerfaud-Valentin, M., Kerever, S., & Sève, P. (2019) · Autoimmunity Reviews

Cytokine Signaling Pathways and InteractionsRheumatoid Arthritis Research and Therapies

Cited by 264

AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity

Di Micco, A., Frera, G., Lugrin, J., Jamilloux, Y., Hsu, E.-T., Tardivel, A., De Gassart, A., Zaffalon, L., Bujisic, B., Siegert, S., et al. (2016) · Proceedings of the National Academy of Sciences

Inflammasome and immune disordersinterferon and immune responses

Cited by 143

Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients

Jamilloux, Y., Cohen-Aubart, F., Chapelon-Abric, C., Maucort-Boulch, D., Marquet, A., Pérard, L., Bouillet, L., Deroux, A., Abad, S., Bielefeld, P., et al. (2017) · Seminars in Arthritis and Rheumatism

Sarcoidosis and Beryllium Toxicity ResearchHistiocytic Disorders and Treatments

Cited by 98

Recovery of adrenal function after long-term glucocorticoid therapy for giant cell arteritis: a cohort study

Jamilloux, Y., Liozon, E., Pugnet, G., Nadalon, S., Heang Ly, K., Dumonteil, S., Gondran, G., Fauchais, A.-L., & Vidal, E. (2013) · PLoS ONE

Adrenal Hormones and DisordersVasculitis and related conditions

Cited by 59

Correction: Recovery of Adrenal Function after Long-Term Glucocorticoid Therapy for Giant Cell Arteritis: A Cohort Study

Jamilloux, Y., Liozon, E., Pugnet, G., Nadalon, S., Heang Ly, K., Dumonteil, S., Gondran, G., Fauchais, A.-L., & Vidal, E. (2013) · PLoS ONE

Adrenal Hormones and DisordersVasculitis and related conditions

Cited by 5